All Pharma News
SQZ opts for liquidation, $11.8M asset fire sale to Stemcell

SQZ opts for liquidation, $11.8M asset fire sale to Stemcell
James Waldron FIERCE BIOTECH
01 Mar 2024
Share Share
STEMCELL Technologies Announces Successful Asset Purchase Agreement with SQZ Bio

STEMCELL Technologies Announces Successful Asset Purchase Agreement with SQZ Bio
BUSINESSWIRE
29 Feb 2024
Share Share
Ahead of shareholder vote on SQZ asset sale and liquidation

Ahead of shareholder vote on SQZ asset sale and liquidation
Amber Tong ENDPTS
14 Feb 2024
Share Share
SQZ founder Armon Sharei opens Portal to cell engineering

SQZ founder Armon Sharei opens Portal to cell engineering
Gabrielle Masson FIERCE BIOTECH
12 Dec 2023
Share Share
SQZ lays off 80% of staff, Regenxbio cuts 15%

SQZ lays off 80% of staff, Regenxbio cuts 15%
James Waldron FIERCE BIOTECH
09 Nov 2023
Share Share
SQZ Biotechnologies Reports Third Quarter 2023 Financial Results

SQZ Biotechnologies Reports Third Quarter 2023 Financial Results
BUSINESSWIRE
08 Nov 2023
Share Share
SQZ Biotechnologies Reports Data for Clinical Programs

SQZ Biotechnologies Reports Data for Clinical Programs
BUSINESSWIRE
03 Nov 2023
Share Share
SQZ Biotechnologies Reports Second Quarter 2023 Financial Results

SQZ Biotechnologies Reports Second Quarter 2023 Financial Results
BUSINESSWIRE
10 Aug 2023
Share Share
Roche drops solid tumor option, intensifying the squeeze on SQZ

Roche drops solid tumor option, intensifying the squeeze on SQZ
Nick Paul Taylor FIERCE BIOTECH
26 Jul 2023
Share Share
SQZ Announces Confirmed Complete Response in HPV16+ Solid Tumor Patient

SQZ Announces Confirmed Complete Response in HPV16+ Solid Tumor Patient
BUSINESSWIRE
22 Mar 2023
Share Share